Dr. Robert T. Foster - 21 Sep 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Dr. Robert T. Foster
Issuer symbol
AUPH
Transactions as of
21 Sep 2023
Net transactions value
$0
Form type
4
Filing time
22 Sep 2023, 16:36:31 UTC
Previous filing
19 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Units Award $0 +20,383 $0.000000 20,383 21 Sep 2023 Common Stock 20,383 Direct F1, F2
transaction AUPH Stock Option (right to buy) Award $0 +32,900 $0.000000 32,900 21 Sep 2023 Common Stock 32,900 $8.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on September 21, 2024
F3 The option vests in twelve equal monthly installments commencing on October 21, 2023.